Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224217531> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4224217531 endingPage "90" @default.
- W4224217531 startingPage "86" @default.
- W4224217531 abstract "Background Successful closure of patent ductus arteriosus (PDA) with ibuprofen or paracetamol as the first-line treatment has been reported, but little is known about factors affecting the closure rate.
 Objective To identify the closure success rate and contributing factors affecting a first course of pharmacological treatment in neonates with PDA.
 Methods A retrospective study was conducted in infants with isolated PDA treated with either ibuprofen or paracetamol and admitted to our neonatal care unit from January 2017 until June 2020. Included infants had PDA on echocardiography and received ibuprofen or paracetamol therapy as the closure treatment. Oral ibuprofen was given at 10 mg/kg on first day, then 5 mg/kg on the 2nd and 3rd days; while paracetamol was given intravenously 15 mg/kg every 6 hours for 3 days. Echocardiographic evaluation was performed 3 days after first course of treatment.
 Results In total, 20 of 33 (60.6%) infants achieved PDA closure with the first course of treatment. Earlier age at the start of the first course of treatment (PR 7.7; 95%CI 1.2 to 47.7; P=0.035) and normal birth weight (PR 13.3; 95%CI 2.4 to 72.4; P=0.001) were significant factors contributing to PDA closure. However, PDA size did not affect closure rate (PR 2.0; 95%CI 0.4 to 8.5; P=0.46).
 Conclusion Pharmacological treatment seems to have a good success rate for PDA closure, with significant positive associations with earlier age at start of treatment and normal birth weight." @default.
- W4224217531 created "2022-04-26" @default.
- W4224217531 creator A5019437957 @default.
- W4224217531 creator A5043172745 @default.
- W4224217531 creator A5055993591 @default.
- W4224217531 date "2022-03-04" @default.
- W4224217531 modified "2023-09-26" @default.
- W4224217531 title "Factors contributing to successful patent ductus arteriosus closure with first pharmacological course" @default.
- W4224217531 cites W1957857943 @default.
- W4224217531 cites W1963623499 @default.
- W4224217531 cites W1967307768 @default.
- W4224217531 cites W1992009244 @default.
- W4224217531 cites W2003552355 @default.
- W4224217531 cites W2012510224 @default.
- W4224217531 cites W2031975950 @default.
- W4224217531 cites W2037094292 @default.
- W4224217531 cites W2042948728 @default.
- W4224217531 cites W2052394049 @default.
- W4224217531 cites W2056054691 @default.
- W4224217531 cites W2087631828 @default.
- W4224217531 cites W2091833213 @default.
- W4224217531 cites W2112740096 @default.
- W4224217531 cites W2129309450 @default.
- W4224217531 cites W2190836993 @default.
- W4224217531 cites W2334286422 @default.
- W4224217531 cites W2752321096 @default.
- W4224217531 cites W2793360052 @default.
- W4224217531 cites W3006187988 @default.
- W4224217531 doi "https://doi.org/10.14238/pi62.2.2022.86-90" @default.
- W4224217531 hasPublicationYear "2022" @default.
- W4224217531 type Work @default.
- W4224217531 citedByCount "0" @default.
- W4224217531 crossrefType "journal-article" @default.
- W4224217531 hasAuthorship W4224217531A5019437957 @default.
- W4224217531 hasAuthorship W4224217531A5043172745 @default.
- W4224217531 hasAuthorship W4224217531A5055993591 @default.
- W4224217531 hasBestOaLocation W42242175311 @default.
- W4224217531 hasConcept C141071460 @default.
- W4224217531 hasConcept C146834321 @default.
- W4224217531 hasConcept C162324750 @default.
- W4224217531 hasConcept C187212893 @default.
- W4224217531 hasConcept C2779944601 @default.
- W4224217531 hasConcept C2781236024 @default.
- W4224217531 hasConcept C34447519 @default.
- W4224217531 hasConcept C42219234 @default.
- W4224217531 hasConcept C71924100 @default.
- W4224217531 hasConcept C98274493 @default.
- W4224217531 hasConceptScore W4224217531C141071460 @default.
- W4224217531 hasConceptScore W4224217531C146834321 @default.
- W4224217531 hasConceptScore W4224217531C162324750 @default.
- W4224217531 hasConceptScore W4224217531C187212893 @default.
- W4224217531 hasConceptScore W4224217531C2779944601 @default.
- W4224217531 hasConceptScore W4224217531C2781236024 @default.
- W4224217531 hasConceptScore W4224217531C34447519 @default.
- W4224217531 hasConceptScore W4224217531C42219234 @default.
- W4224217531 hasConceptScore W4224217531C71924100 @default.
- W4224217531 hasConceptScore W4224217531C98274493 @default.
- W4224217531 hasIssue "2" @default.
- W4224217531 hasLocation W42242175311 @default.
- W4224217531 hasOpenAccess W4224217531 @default.
- W4224217531 hasPrimaryLocation W42242175311 @default.
- W4224217531 hasRelatedWork W177019059 @default.
- W4224217531 hasRelatedWork W2001431596 @default.
- W4224217531 hasRelatedWork W2368829227 @default.
- W4224217531 hasRelatedWork W2389543151 @default.
- W4224217531 hasRelatedWork W2414428146 @default.
- W4224217531 hasRelatedWork W2425016358 @default.
- W4224217531 hasRelatedWork W2530816000 @default.
- W4224217531 hasRelatedWork W3030284760 @default.
- W4224217531 hasRelatedWork W3087597853 @default.
- W4224217531 hasRelatedWork W37660807 @default.
- W4224217531 hasVolume "62" @default.
- W4224217531 isParatext "false" @default.
- W4224217531 isRetracted "false" @default.
- W4224217531 workType "article" @default.